We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Top Buys

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$174M
2
EQIX icon
Equinix
EQIX
+$83.3M
3
DLR icon
Digital Realty Trust
DLR
+$82.9M
4
PLD icon
Prologis
PLD
+$52.3M
5
INVH icon
Invitation Homes
INVH
+$39.6M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$263M
2
VICI icon
VICI Properties
VICI
+$230M
3
ESS icon
Essex Property Trust
ESS
+$96.1M
4
VTR icon
Ventas
VTR
+$61.2M
5
EBIZ icon
Global X E-commerce ETF
EBIZ
+$39.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZWS icon
1401
Zurn Elkay Water Solutions
ZWS
$8.14B
– –
-36,800
Closed -$1.3M
LENZ
1402
LENZ Therapeutics
LENZ
$179M
$0 ﹤0.01%
24
– –
QTTB icon
1403
Q32 Bio
QTTB
$452M
$0 ﹤0.01%
6
– –
TECX
1404
Tectonic Therapeutic
TECX
$578M
$0 ﹤0.01%
7
– –
SYRS
1405
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$0 ﹤0.01%
10
– –
NKLA
1406
DELISTED
Nikola Corporation Common Stock
NKLA
– –
-432
Closed -$139K
SUM
1407
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
– –
-10,170
Closed -$311K
PSTX
1408
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$0 ﹤0.01%
116
– –
GRTS
1409
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$0 ﹤0.01%
198
-10,869
-98% -$28.5K
TBIO
1410
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$0 ﹤0.01%
5
– –
ASXC
1411
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-95,198
Closed -$60K
MRNS
1412
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$0 ﹤0.01%
58
– –
EIGR
1413
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$0 ﹤0.01%
2
– –
GMDA
1414
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$0 ﹤0.01%
93
– –
SOLO
1415
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
– –
-46,770
Closed -$101K
CBAY
1416
DELISTED
Cymabay Therapeutics
CBAY
$0 ﹤0.01%
152
– –
CYT
1417
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$0 ﹤0.01%
103
– –
RPT.PRD
1418
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
– –
-3,214
Closed -$191K
AMTI
1419
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$0 ﹤0.01%
132
– –
PRTK
1420
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$0 ﹤0.01%
86
– –
SURF
1421
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$0 ﹤0.01%
77
– –
HARP
1422
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$0 ﹤0.01%
5
– –
SPPI
1423
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$0 ﹤0.01%
321
– –
EVLO
1424
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$0 ﹤0.01%
8
– –
TCRR
1425
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$0 ﹤0.01%
131
– –
54 55 56
57
58

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.